Global CAR T-cell Therapy Market 2018-2022
About CAR T-cell Therapy
Chimeric antigen receptor (CAR) is one of the recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology. CARs are engineered receptors to attack cancer cells. In this therapy, patients’ T-cells are modified to attack cancer cells. In this therapy, patients’ T-cells are modified in the laboratory to fight against various cancer indications.
Technavio’s analysts forecast the Global CAR T-cell Therapy Market to grow at a CAGR of 63.15% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the CAR T-cell therapy market. To calculate the market size, the report considers the revenue generated from the application of CAR T-cell therapy across the globe.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Key vendors
- bluebird bio
- CARsgen Therapeutics
- Celgene
- Gilead
- Novartis
- Proven effectiveness of CAR T-cell therapy
- For a full, detailed list, view our report
- High cost of CAR T-cell therapy
- For a full, detailed list, view our report
- Collaborative R&D efforts
- For a full, detailed list, view our report
- What will the market size be in 2022 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
- Executive summary
- Scope of the report
- Research methodology
- Market landscape
- Market ecosystem
- Table Parent market: Global regenerative medicines market
- Table Global regenerative medicines market segmentation
- Market characteristics
- Table Market characteristics: Overview
- Market segmentation analysis
- Table Market segments
- Market ecosystem
- Market sizing
- Market definition
- Table CAR T-cell therapy process
- Table CAR T-cell therapy - Market overview
- Table Market definition - Inclusions and exclusions checklist
- Market sizing 2017
- Table Market size 2017
- Table Validation techniques employed for market sizing 2017
- Market size and forecast 2017-2022
- Table Global CAR T-cell therapy market - Market size and forecast 2017-2022 ($ mn)
- Table Global CAR T-cell therapy market - Year-over-year growth 2018-2022 (%)
- Market definition
- Five forces analysis
- Table Five forces analysis 2017
- Table Five forces analysis 2022
- Bargaining power of buyers
- Table Bargaining power of buyers
- Bargaining power of suppliers
- Table Bargaining power of suppliers
- Threat of new entrants
- Table Threat of new entrants
- Threat of substitutes
- Table Threat of substitutes
- Threat of rivalry
- Table Threat of rivalry
- Market condition
- Table Market condition - Five forces 2017
- Pipeline
- Table Major indications covered under CAR T-cell therapy R&D landscape
- Table Global CAR T-cell therapy market pipeline: Overview
- Table CAR T-cell therapy pipeline: Overview
- Market segmentation by antigen
- Segmentation by antigen
- Table Global CAR T-cell therapy market - Market share by antigen 2017-2022 (%)
- Comparison by antigen
- Table Comparison by antigen
- CD19 - Market size and forecast 2017-2022
- Table Global CAR T-cell therapy market by CD19 - Market size and forecast 2017-2022 ($ mn)
- Table Global CAR T-cell therapy market by CD19 - Year-over-year growth 2018-2022 (%)
- CD22 - Market size and forecast 2017-2022
- Table Global CAR T-cell therapy market by CD22 - Market size and forecast 2017-2022 ($ mn)
- Table Global CAR T-cell therapy market by CD22 - Year-over-year growth 2018-2022 (%)
- Others - Market size and forecast 2017-2022
- Table Global CAR T-cell therapy market by others - Market size and forecast 2017-2022 ($ mn)
- Table Other antigens: Overview
- Table Global CAR T-cell therapy market by others - Year-over-year growth 2018-2022 (%)
- Market opportunity by antigen
- Table Market opportunity by antigen
- Segmentation by antigen
- Customer landscape
- Table Customer landscape
- Regional landscape
- Geographical segmentation
- Table Global CAR T-cell therapy - Market share by geography 2017-2022 (%)
- Regional comparison
- Table Regional comparison
- Americas - Market size and forecast 2017-2022
- Table CAR T-cell therapy market in Americas - Market size and forecast 2017-2022 ($ mn)
- Table CAR T-cell therapy market in Americas - Overview
- Table CAR T-cell therapy market in Americas - Year-over-year growth 2018-2022 (%)
- EMEA - Market size and forecast 2017-2022
- Table CAR T-cell therapy market in EMEA - Market size and forecast 2017-2022 ($ mn)
- Table CAR T-cell therapy market in EMEA - Overview
- Table CAR T-cell therapy market in EMEA - Year-over-year growth 2018-2022 (%)
- APAC - Market size and forecast 2017-2022
- Table CAR T-cell therapy market in APAC - Market size and forecast 2017-2022 ($ mn)
- Table CAR T-cell therapy market in APAC - Overview
- Table CAR T-cell therapy market in APAC - Year-over-year growth 2018-2022 (%)
- Key leading countries
- Table Key leading countries: Overview
- Market opportunity
- Table Market opportunity
- Geographical segmentation
- Decision framework
- Drivers and challenges
- Market drivers
- Market challenges
- Table Segmentation of therapies in research based on tumor type
- Market trends
- Collaborative R&D efforts
- Reimbursement coverage
- Advent of armored CAR T-cells
- Vendor landscape
- Overview
- Table Vendor landscape
- Landscape disruption
- Table Landscape disruption
- Overview
- Vendor analysis
- Vendors covered
- Table Vendors covered: Overview
- Vendor classification
- Table Vendor classification: Overview
- Market positioning of vendors
- Table Market positioning of vendors: Overview
- bluebird bio
- Table bluebird bio - Overview
- Table bluebird bio - Business segments
- Table bluebird bio - Organizational developments
- Table bluebird bio - Key offerings
- Table bluebird bio - Key customers
- CARsgen Therapeutics
- Table CARsgen Therapeutics - Overview
- Table CARsgen Therapeutics - Business segments
- Table CARsgen Therapeutics - Organizational developments
- Table CARsgen Therapeutics - Key offerings
- Table CARsgen Therapeutics - Key customers
- Celgene
- Table Celgene - Overview
- Table Celgene - Business segments
- Table Celgene - Organizational developments
- Table Celgene - Geographic focus
- Table Celgene - Key offerings
- Table Celgene - Key customers
- Gilead
- Table Gilead - Overview
- Table Gilead - Business segments
- Table Gilead - Organizational developments
- Table Gilead - Geographic focus
- Table Gilead - Key offerings
- Table Gilead - Key customers
- Novartis
- Table Novartis - Overview
- Table Novartis - Business segments
- Table Novartis - Organizational developments
- Table Novartis - Geographic focus
- Table Novartis - Segment focus
- Table Novartis - Key offerings
- Table Novartis - Key customers
- Vendors covered
- Appendix
- List of abbreviations
- Explore Technavio
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook